Entities / Company
Biofrontera.
Company
- Reports this week
- 0
- Active events
- 0
- Connections
- 15
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
One to three months ago
-
Biofrontera submitted a supplemental New Drug Application (sNDA) to the FDA, involving research associated with Roswell Park.Some support1 report
-
Biofrontera and Inhibikase Therapeutics are both identified as small-cap healthcare companies.Some support1 report
-
A hedge fund filed documents with the US SEC regarding Biofrontera.Some support1 report
-
Geode Capital Management raised its position in Biofrontera stock on August 30, 2026.Some support1 report
Gone quiet
No new reports in 90+ days-
Biofrontera's acquisition of George Jones includes rights to FDA approval and strengthens commercial efforts.Some support1 report1 development inside
-
Biofrontera commercializes its products in the US market.Some support1 report
-
Biofrontera started using LinkedIn for company following.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Biofrontera this week
News at the entities that move Biofrontera most-
FDA StructuralFDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.Moves Biofrontera
-
Geode Capital Management TransactionalGeode Capital Management, Mizuho Securities, and Manufacturers Life Insurance Company increased their holdings and raised their target price/rating on MBX Biosciences stock.Moves Biofrontera
-
LinkedIn Mentioned togetherA company with FDA-approved therapies used LinkedIn for information and its board approved a stock award for CFO hiring.Moves Biofrontera
-
AstraZeneca Mentioned togetherAstraZeneca developed the drug Ultomiris, supported by the UAE's Emirates Drug Establishment (EDE).Moves Biofrontera
Connections
The 6 strongest of 15, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
FDA formally regulates Biofrontera's drug development, requiring safety validation and approval for market access.
-
Geode Capital Management Transactional
Geode Capital Management raised its position in Biofrontera stock.
-
LinkedIn Mentioned together
Biofrontera utilizes LinkedIn for professional presence and company following.
-
AstraZeneca Mentioned together
The companies are co-mentioned in the context of being compared for investment.
-
Roswell Park Comprehensive Cancer Center Mentioned together
Both entities are noted to operate within the same scientific field.
-
Arcturus Therapeutics Mentioned together
The two companies are co-mentioned as part of the biotech sector experiencing rating changes.
History
Events by the month they beganOctober 2026
3 events- Eton Pharmaceuticals and Biofrontera, small-cap healthcare companies, are noted for their revenue and earnings, with MarketBeat providing analyst ratings.
- Biofrontera and AstraZeneca are being compared as healthcare companies for investment.
- Biofrontera submitted a supplemental New Drug Application (sNDA) to the FDA, involving research associated with Roswell Park.